Andexanet alfa

What is Andexanet alfa?

Andexanet alfa, marketed as Ondexxya or Andexxa, is a modified recombinant human Factor Xa protein. It serves as a specific reversal agent for patients experiencing acute major or life-threatening severe bleeding associated with direct oral Factor Xa inhibitors (DOACs) like rivaroxaban (Xarelto) and apixaban (Eliquis). This groundbreaking medication rapidly neutralizes the anticoagulant effect, offering a crucial intervention in emergencies where prompt hemostasis is vital.

How Does it Work?

Andexanet alfa's mechanism is highly targeted. It's a catalytically inactive Factor Xa molecule, engineered to not participate in the coagulation cascade itself. Instead, it acts as a "decoy," binding to and sequestering circulating Factor Xa inhibitors with high affinity. By binding these anticoagulant drugs, it removes them from their target (endogenous Factor Xa), preventing inhibition of the normal clotting process. This restores natural Factor Xa activity, leading to increased thrombin generation and re-establishment of the body's hemostatic mechanisms, effectively stopping severe bleeding.

Medical Uses

The primary medical use of Andexanet alfa is the reversal of the anticoagulant effect of rivaroxaban and apixaban in adult patients experiencing uncontrolled or life-threatening bleeding. This includes critical events like intracranial hemorrhage or major gastrointestinal bleeding. Before Andexanet alfa, specific antidotes for direct Factor Xa inhibitors were unavailable. Its approval revolutionized the management of high-risk patients, providing a targeted solution. It is specifically indicated for certain Factor Xa inhibitors, not other anticoagulants.

Dosage

The recommended dosage of Andexanet alfa depends on the specific Factor Xa inhibitor and time since the last dose. It's administered intravenously as a bolus followed by a continuous infusion.

• Low-Dose Regimen:

  For low doses of rivaroxaban (≤10 mg) or apixaban (≤5 mg) taken less than 8 hours ago, or if time is unknown but suspected within 8 hours. This typically involves a 400 mg IV bolus followed by a 4 mg/minute infusion for 120 minutes.

• High-Dose Regimen:

  For high doses of rivaroxaban (>10 mg) or apixaban (>5 mg), or if more than 8 hours have passed, or time is unknown but suspected beyond 8 hours. This involves an 800 mg IV bolus followed by an 8 mg/minute infusion for 120 minutes.

Healthcare professionals must carefully assess bleeding severity and anticoagulant history.

Side Effects

While life-saving, Andexanet alfa has potential serious side effects. Common reactions include infusion-related responses (flushing, warmth, rash), urinary tract infections, and pneumonia.

A significant concern is the risk of thromboembolic events, including ischemic stroke, myocardial infarction, and deep vein thrombosis. This risk is elevated in patients who already have conditions necessitating Factor Xa inhibitor reversal. Re-establishing hemostasis removes the anticoagulant's protective effect, potentially leading to a prothrombotic state.

A "Black Box Warning" highlights the potential for arterial and venous thromboembolic events and ischemic events. Patients require close monitoring for thrombosis. Resumption of anticoagulant therapy should be considered as soon as medically appropriate.

Drug Interactions

The primary "interaction" of Andexanet alfa is its intended reversal of direct Factor Xa inhibitors (rivaroxaban, apixaban). It is specifically designed to bind and neutralize these anticoagulants.

Limited data exists for interactions with other medications. It is not indicated for reversing other anticoagulant classes (e.g., direct thrombin inhibitors, heparin, vitamin K antagonists). Use with other procoagulant agents or blood products requires careful physician consideration, balancing risks and benefits.

FAQ

What is Andexanet alfa used for?

• Andexanet alfa reverses the anticoagulant effects of Factor Xa inhibitors (rivaroxaban and apixaban) in patients with life-threatening or uncontrolled bleeding.

How quickly does Andexanet alfa work?

• It works very rapidly. Significant reduction in anti-Factor Xa activity occurs within minutes of bolus administration, with sustained reversal during infusion.

Is Andexanet alfa safe for everyone?

• While effective, it carries a risk of thromboembolic events. Its use requires careful assessment of clotting risk and is generally reserved for severe bleeding where benefits outweigh risks.

What are the brand names for Andexanet alfa?

• Andexanet alfa is marketed as Ondexxya (Europe) and Andexxa (United States).

Products containing Andexanet alfa are available through trusted online pharmacies. You can browse Andexanet alfa-based medications at ShipperVIP or Medicenter.

Summary

Andexanet alfa is a significant advancement in emergency medicine, providing a targeted reversal agent for the anticoagulant effect of direct Factor Xa inhibitors in patients with acute major bleeding. Its unique mechanism rapidly restores hemostasis by sequestering the anticoagulant drugs. While life-saving, its use requires careful patient selection and monitoring due to the inherent risk of thromboembolic events following reversal. It is a crucial tool balancing thrombosis prevention and emergent hemorrhage management.